• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of Stemness Factor Lgr4 for Therapeutic Resistance in CML Stem Cells

Research Project

Project/Area Number 17H03578
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section一般
Research Field Tumor biology
Research InstitutionHiroshima University

Principal Investigator

Naka Kazuhito  広島大学, 原爆放射線医科学研究所, 准教授 (70372688)

Co-Investigator(Kenkyū-buntansha) 坂本 直也  広島大学, 医系科学研究科(医), 助教 (20571798)
Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥17,940,000 (Direct Cost: ¥13,800,000、Indirect Cost: ¥4,140,000)
Fiscal Year 2019: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2018: ¥6,110,000 (Direct Cost: ¥4,700,000、Indirect Cost: ¥1,410,000)
Fiscal Year 2017: ¥5,720,000 (Direct Cost: ¥4,400,000、Indirect Cost: ¥1,320,000)
Keywordsがん幹細胞 / CML幹細胞 / 抗がん剤抵抗性 / Lgr4 / Wnt/beta-catenin / Foxo3a / CML / 代謝 / Wnt-beta-catenin / Wnt-beta-Catenin / Wnt/β-catenin / ゲノム編集 / 癌 / Wnt-β-catenin
Outline of Final Research Achievements

Recently, we found elevated expression of Lgr4/Gpr48, which encodes a leucine-rich repeat (LRR)-containing GPCR, in the most primitive long-term CML stem cells by RNA-Seq. Although the Lgr5/Gpr49 gene is reportedly responsible for the maintenance of intestinal and cancer stem cells, the biological function of Lgr4/Gpr48 is not yet fully understood. Here we investigated the role of Lgr4 in CML stem cells. To evaluate the self-renewal capacity of the CML-initiating cells in vivo, we performed bone marrow transplantation of CML LSK cells from Lgr4 gene trap (Gt) or wild type mice into irradiated recipients. To our surprise, Lgr4 Gt CML LSK cells displayed attenuated disease-initiating capacity in transplanted recipients. Importantly, the frequency and absolute number of CML LSK cells were significantly decreased in Lgr4 Gt CML mice compared with wild type CML mice. Thus, these results indicated that Lgr4 plays an important role for the long-term maintenance of CML stem cells in vivo.

Academic Significance and Societal Importance of the Research Achievements

がん細胞中には,非常に少数ながら多くのがん細胞を生み出すがん幹細胞が存在する.このがん幹細胞は抗がん剤に対して抵抗性を示し,残存したがん幹細胞は再発の原因となる.そのため,がんの再発を克服するには,がん幹細胞の制御メカニズムの解明が重要である.本研究では,新たにLgr4/Gpr48がCML幹細胞の未分化性の維持に重要な役割を担うことを解明した.本研究成果は,Lgr4/Gpr48によるFoxo3aと活性化β-cateninの相互作用を制御する分子機構の解明,並びに副作用の少ない新しいCML幹細胞の治療法を開発するための分子基盤となる.

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Annual Research Report
  • 2017 Annual Research Report
  • Research Products

    (26 results)

All 2020 2019 2018 2017 Other

All Int'l Joint Research (3 results) Journal Article (5 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 4 results,  Open Access: 1 results) Presentation (15 results) (of which Int'l Joint Research: 5 results,  Invited: 11 results) Patent(Industrial Property Rights) (3 results) (of which Overseas: 1 results)

  • [Int'l Joint Research] ソウル国立大学校(韓国)

    • Related Report
      2019 Annual Research Report
  • [Int'l Joint Research] ソウル国立大学校(韓国)

    • Related Report
      2018 Annual Research Report
  • [Int'l Joint Research] ソウル国立大学校(韓国)

    • Related Report
      2017 Annual Research Report
  • [Journal Article] Targeting of plasminogen activator inhibitor-1 activity promotes elimination of chronic myeloid leukemia stem cells2020

    • Author(s)
      Yahata Takashi、Ibrahim Abd Aziz、Hirano Ken-ichi、Muguruma Yukari、Naka Kazuhito、Hozumi Katsuto、Vaughan Douglas E.、Miyata Toshio、Ando Kiyoshi
    • Journal Title

      Haematologica

      Volume: 105 Issue: 2 Pages: 483-494

    • DOI

      10.3324/haematol.2019.230227

    • Related Report
      2019 Annual Research Report
    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] CML幹細胞の維持におけるSirt1の役割2020

    • Author(s)
      2.仲 一仁
    • Journal Title

      血液内科

      Volume: 80 Pages: 455-460

    • NAID

      40022199215

    • Related Report
      2019 Annual Research Report
  • [Journal Article] HMGCLL1 is a predictive biomarker for deep molecular response to imatinib therapy in chronic myeloid leukemia.2018

    • Author(s)
      Park J.-H., Woo Y.-M., Youm E., Hamad N., Won H.-H., Naka K., Park E.-J., Park J.-H., Kim H.J., Kim S.-H., Kim H., Ahn J.-S., Sohn S.-K., Moon J.-H., Jung C.-W., Park S., Lipton J., Kimura S., Jong-Won Kim J.-W., Kim D.
    • Journal Title

      Leukemia

      Volume: epub ahead of print Issue: 6 Pages: 1439-1450

    • DOI

      10.1038/s41375-018-0321-8

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Metabolic regulation specific to leukemia stem cells2017

    • Author(s)
      仲 一仁
    • Journal Title

      Rinsho Ketsueki

      Volume: 58 Issue: 10 Pages: 1818-1827

    • DOI

      10.11406/rinketsu.58.1818

    • NAID

      130006132648

    • ISSN
      0485-1439, 1882-0824
    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Regulation of hematopoiesis and hematological disease by TGF-β family signaling molecules2017

    • Author(s)
      Naka K., and Hirao A.
    • Journal Title

      Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins

      Volume: 9(9) Issue: 9 Pages: 839-863

    • DOI

      10.1101/cshperspect.a027987

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed
  • [Presentation] Nutrient Supply Specific to CML Stem Cells2019

    • Author(s)
      Kazuhito Naka
    • Organizer
      29th Symposium of the International Association for Comparative Research on Leukemia and Related Diseases
    • Related Report
      2019 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] マウスモデルを用いた慢性骨髄性白血病発症におけるIL-27の抗腫瘍効果2018

    • Author(s)
      折井直子,溝口出,長谷川英哲, 義本隆之, 仲一仁
    • Organizer
      第77回日本癌学会学術総会
    • Related Report
      2018 Annual Research Report
  • [Presentation] PAI-1活性の阻害による慢性骨髄性白血病幹細胞の治療高感受性化2018

    • Author(s)
      八幡崇, Abd Aziz Ibrahim, 仲 一仁,宮田敏男,安藤潔
    • Organizer
      第80回日本血液学会学術集会
    • Related Report
      2018 Annual Research Report
  • [Presentation] Novel therapeutic strategy targeting nutrient supply specific to chronic myelogenous leukemia stem cells2018

    • Author(s)
      Kazuhito Naka, and Seong-Jin Kim
    • Organizer
      The 9th Japanese Society of Hematology International Symposium 2018
    • Related Report
      2018 Annual Research Report
    • Int'l Joint Research
  • [Presentation] 幹細胞の栄養・代謝システムを標的とするがん再発治療法の開発2018

    • Author(s)
      仲 一仁
    • Organizer
      大阪府商工労働部平成29年度 創薬シーズ事業化コンペティション
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] Novel therapeutic strategy targeting nutrient supply of chronic myelogenous leukemia stem cells2017

    • Author(s)
      Kazuhito Naka, and Wataru Yasui
    • Organizer
      Special Session TMP (Translational Molecular Pathology) Division of Pathology Meeting Series
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Novel therapeutic strategy targeting nutrient supply of chronic myelogenous leukemia stem cells2017

    • Author(s)
      Kazuhito Naka, Yoshihiro Takihara, Ichinohe Tatsuo, Eisuke Hida, Yukio Kato, Wataru Yasui, and Seong-Jin Kim
    • Organizer
      Global Academic Programs 2017 Conference
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] CML幹細胞の新しい治療戦略2017

    • Author(s)
      仲 一仁
    • Organizer
      Hematology Seminar in KAGOSHIMA
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] 幹細胞における新しいシグナル伝達研究 (ランチョンセミナー)2017

    • Author(s)
      仲 一仁
    • Organizer
      第40回日本神経科学大会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] CML幹細胞の新しい治療戦略2017

    • Author(s)
      仲 一仁
    • Organizer
      第40回八幡平血液セミナー
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] Discovery of novel therapeutics targeting CML stem cells by Duolink technology2017

    • Author(s)
      仲 一仁
    • Organizer
      Scientist Round Table
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] Duolink PLA技術を用いたCML幹細胞のシグナル伝達研究と前臨床試験への応用 (ランチョンセミナー)2017

    • Author(s)
      仲 一仁
    • Organizer
      第76回日本癌学会学術総会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] Novel therapeutic strategy targeting nutrition specific to CML stem cells2017

    • Author(s)
      仲 一仁
    • Organizer
      Metabolon Seminar ~メタボロミクス・リピドミクスの最前線~
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] 特別教育講演「代謝を標的とした白血病幹細胞制御」2017

    • Author(s)
      仲 一仁
    • Organizer
      第79回日本血液学会学術集会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] CML幹細胞の新しい治療戦略 ~Novel therapeutic strategy for eliminating CML stem cells~2017

    • Author(s)
      仲 一仁
    • Organizer
      BMS CML Symposium 2017 in Hiroshima
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Patent(Industrial Property Rights)] 5FU耐性癌治療用医薬組成物2019

    • Inventor(s)
      安井 弥,坂本直也,鵜飼翔一,本間りりの,仲 一仁
    • Industrial Property Rights Holder
      国立大学法人広島大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2019-167410
    • Filing Date
      2019
    • Related Report
      2019 Annual Research Report
  • [Patent(Industrial Property Rights)] 新規アミノピラゾール誘導体2019

    • Inventor(s)
      澤 匡明, 森山 英樹, 大本 弘志, 仲 一仁
    • Industrial Property Rights Holder
      カルナバイオサイエンス株式会社, 国立大学法人広島大学
    • Industrial Property Rights Type
      特許
    • Filing Date
      2019
    • Related Report
      2019 Annual Research Report
    • Overseas
  • [Patent(Industrial Property Rights)] 新規アミノピラゾール誘導体2018

    • Inventor(s)
      澤 匡明, 森山 英樹, 大本 弘志, 仲 一仁
    • Industrial Property Rights Holder
      カルナバイオサイエンス株式会社, 広島大学
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-243575
    • Filing Date
      2018
    • Related Report
      2018 Annual Research Report

URL: 

Published: 2017-04-28   Modified: 2021-02-19  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi